PL1617836T3 - Kompozycja odżywcza lub lecznicza zawierająca oleuropeinę lub jedną z jej pochodnych - Google Patents

Kompozycja odżywcza lub lecznicza zawierająca oleuropeinę lub jedną z jej pochodnych

Info

Publication number
PL1617836T3
PL1617836T3 PL04742843T PL04742843T PL1617836T3 PL 1617836 T3 PL1617836 T3 PL 1617836T3 PL 04742843 T PL04742843 T PL 04742843T PL 04742843 T PL04742843 T PL 04742843T PL 1617836 T3 PL1617836 T3 PL 1617836T3
Authority
PL
Poland
Prior art keywords
bone
derivatives
animals
stimulating
formation
Prior art date
Application number
PL04742843T
Other languages
English (en)
Inventor
Véronique Coxam
Leandros Skaltsounis
Caroline Puel
André Mazur
Original Assignee
Inst Nat De La Rech Agronomique Inra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat De La Rech Agronomique Inra filed Critical Inst Nat De La Rech Agronomique Inra
Publication of PL1617836T3 publication Critical patent/PL1617836T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
PL04742843T 2003-04-11 2004-04-09 Kompozycja odżywcza lub lecznicza zawierająca oleuropeinę lub jedną z jej pochodnych PL1617836T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0304584A FR2853549B1 (fr) 2003-04-11 2003-04-11 Composition nutritionnelle ou therapeutique contenant le compose oleuropeine ou l'un de ses derives
EP04742843A EP1617836B1 (fr) 2003-04-11 2004-04-09 Composition nutritionelle ou therapeutique contenant le compose oleuropeine ou l'un de ses derives
PCT/FR2004/050156 WO2004091591A2 (fr) 2003-04-11 2004-04-09 Composition nutritionnelle ou therapeutique contenant le compose oleurofeine ou l'un de ses derives

Publications (1)

Publication Number Publication Date
PL1617836T3 true PL1617836T3 (pl) 2012-05-31

Family

ID=33041820

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04742843T PL1617836T3 (pl) 2003-04-11 2004-04-09 Kompozycja odżywcza lub lecznicza zawierająca oleuropeinę lub jedną z jej pochodnych

Country Status (9)

Country Link
US (1) US8138224B2 (pl)
EP (1) EP1617836B1 (pl)
AT (1) ATE535240T1 (pl)
CA (1) CA2521967C (pl)
DK (1) DK1617836T3 (pl)
ES (1) ES2378154T3 (pl)
FR (1) FR2853549B1 (pl)
PL (1) PL1617836T3 (pl)
WO (1) WO2004091591A2 (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2274721B1 (es) * 2005-11-03 2008-06-01 Laboratorios Belmac, S.A. Nuevo agente terapeutico para el tratamiento de una condicion asociada a la enfermedad vascular periferica.
CN101646433B (zh) * 2006-10-24 2011-11-16 戴维·W·克雷姆平 抗再吸收的和造骨的食物增补剂和使用方法
EP1982707A1 (en) * 2007-04-18 2008-10-22 DSMIP Assets B.V. Use of hydroxytyrosol as anti-aging agent
JP2009227616A (ja) * 2008-03-24 2009-10-08 Toin Gakuen オレウロペイン及び／又はヒドロキシチロソールを有効成分として含有する骨形成促進剤
GB0807673D0 (en) * 2008-04-28 2008-06-04 Bio Actor Bcba Polyphenolic extract
ITMI20082122A1 (it) * 2008-11-28 2010-05-29 New Life Hold S R L Nuova miscela per panificazione
US7897184B1 (en) 2009-08-13 2011-03-01 Access Business Group International Llc Topical composition with skin lightening effect
WO2012060884A1 (en) * 2010-11-04 2012-05-10 Nestec S.A. Methods and compositions for preventing and treating osteoarthritis
JP2016520544A (ja) * 2013-04-05 2016-07-14 ネステク ソシエテ アノニム 骨成長の刺激における使用のための組成物
CN113101297A (zh) * 2013-05-29 2021-07-13 雀巢产品有限公司 用于软骨破坏的组合物
WO2015055468A1 (en) * 2013-10-14 2015-04-23 Nestec S.A. Anti-inflammatory phytonutrients for use in the treatment or prevention of synovitis
ITUB20150541A1 (it) 2015-03-03 2016-09-03 Acraf Composizione comprendente sostanze e/o estratti naturali
ITUA20163791A1 (it) * 2016-05-25 2017-11-25 Alfonso Colacchio Composto nutraceutico per il potenziamento del sistema immunitario ed il benessere delle ossa
CN106804629B (zh) * 2017-01-17 2020-07-17 长江大学 对节白蜡中具有杀菌活性的提取物及其杀菌组合物
JP7304346B2 (ja) * 2017-11-08 2023-07-06 ソシエテ・デ・プロデュイ・ネスレ・エス・アー ホモバニリルアルコール（ｈｖａ）、ｈｖａ異性体、このような化合物を含む組成物の作製方法、及びこのような化合物を使用する方法
JP2022533036A (ja) * 2019-05-13 2022-07-21 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 化合物オレウロペイン又はその代謝産物を使用して代謝疲労を治療又は予防する組成物及び方法
CA3140227A1 (en) * 2019-05-13 2020-11-19 Societe Des Produits Nestle S.A. Compositions and methods using a combination of calcium and at least one of oleuropein or metabolite thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4761406A (en) 1985-06-06 1988-08-02 The Procter & Gamble Company Regimen for treating osteoporosis
WO1996014064A1 (en) * 1994-11-07 1996-05-17 Strecker, Robert, B. Method and composition for antiviral therapy
US5714150A (en) * 1997-01-08 1998-02-03 Nachman; Leslie Method for producing extract of olive leaves
US20010046977A1 (en) * 1997-11-25 2001-11-29 Merck & Co., Inc. Use of alendronate for the prevention of osteoporosis
US6117476A (en) * 1999-01-04 2000-09-12 Shaul Eger Healthy food spreads
ES2157178B1 (es) * 1999-12-23 2002-02-16 Asac Compania De Biotecnologia Procedimiento de obtencion de extractos de olea europaea y aplicaciones de los mismos.
US6437004B1 (en) * 2000-04-06 2002-08-20 Nicholas V. Perricone Treatment of skin damage using olive oil polyphenols
AU5311301A (en) * 2000-04-20 2001-11-07 Upjohn Co Use of thioamide oxazolidinones for the treatment of bone resorption and osteoporosis
US6440465B1 (en) * 2000-05-01 2002-08-27 Bioderm, Inc. Topical composition for the treatment of psoriasis and related skin disorders
JP2002128678A (ja) * 2000-10-17 2002-05-09 Tama Seikagaku Kk オレウロペインを含有する抽出組成物の製造方法
US6455070B1 (en) * 2001-02-15 2002-09-24 East Park Research, Inc. Composition for treating symptoms of influenza
PT1397105E (pt) * 2001-05-23 2006-12-29 Hamdi K Hamdi Composições para inibir angiogénese
CN1646093A (zh) * 2002-02-13 2005-07-27 克雷农业公司 治疗炎症和与aids关联的神经紊乱的方法和组合物
US7445807B2 (en) * 2002-10-15 2008-11-04 Western Holdings, Llc Agglomerated granular protein-rich nutritional supplement

Also Published As

Publication number Publication date
FR2853549A1 (fr) 2004-10-15
EP1617836B1 (fr) 2011-11-30
EP1617836A2 (fr) 2006-01-25
ATE535240T1 (de) 2011-12-15
ES2378154T3 (es) 2012-04-09
US20060193931A1 (en) 2006-08-31
CA2521967A1 (fr) 2004-10-28
US8138224B2 (en) 2012-03-20
WO2004091591A3 (fr) 2004-11-25
WO2004091591A2 (fr) 2004-10-28
DK1617836T3 (da) 2012-03-19
FR2853549B1 (fr) 2007-11-09
CA2521967C (fr) 2012-08-21

Similar Documents

Publication Publication Date Title
PL1617836T3 (pl) Kompozycja odżywcza lub lecznicza zawierająca oleuropeinę lub jedną z jej pochodnych
ECSP055680A (es) Nuevos compuestos de imidazol como inhibidores del factor de crecimiento transformante (tgf)
ECSP055681A (es) Nuevos compuestos de triazol como inhibidores del factor de crecimiento transformante (tgf)
UY28214A1 (es) Nuevos compuestos heteroaromáticos condensados que son inhibidores del factor de crecimiento transformante (tgf)
UY27985A1 (es) Nuevos compuestos de imidazol domo inhibidores del factor de crecimiento transformante (tgf)
RU95113347A (ru) Спиропиперидины и их гомологи, способ получения, способ повышения уровней эндогенного гормона роста, способ лечения остеопороза, фармацевтическая композиция
ATE402929T1 (de) Pyrazinverbindungen als inhibitoren des transforming growth factor (tgf)
BR0116001A (pt) Métodos para tratar distúrbios neuropsiquiátricos com antagonistas receptores nmda
BRPI0408236A (pt) método para radiofluoração, composto, composição radiofarmacêutica, uso de um composto, e, métodos para gerar uma imagem de um corpo humano ou animal e para monitorar o efeito de tratamento de um corpo humano ou animal com um medicamento para combater uma condição associada com cáncer
BRPI0515446A (pt) amidas bicìclicas como inibidores de cinases
ES2158103T3 (es) Derivados de benzofurano utiles como inhibidores de la resorcion osea.
IL192557A (en) Imidazole derivatives are conserved and used as ptpase inhibitors
BR0317888A (pt) Cristais do hormÈnio do crescimento humano e processos para preparação dos mesmos
BR0013879A (pt) Melhoria da condição de saúde de animais de estimação de idade avançada
AR010700A1 (es) Derivados de purina sustituidos, procedimiento para su preparacion, su empleo y su agente que los contiene
AU2284001A (en) Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone
PL1747220T3 (pl) Podstawione 1H-pirolo[3,2-b, 3,2-c i 2,3-c]pirydyno-2-karboksyamidy oraz pokrewne analogi jako inhibitory kinazy kazeinowej l epsilon
BRPI0512274A (pt) derivados de piperazina aril-substituìdos
DE60315842D1 (de) Verwendung von hesperidin oder einem seiner derivate zur herstellung eines medikaments für die stimulierung der knochenbildung
DE60018409D1 (de) Verwendung von antiseptika zur herstelllung von arzneimitteln zur prophylaxe und behandlung von infektionen und/ oder funktionellen gewebeumformungen im körperinneren
ATE253904T1 (de) Verwendung von pharmazeutische zusammensetzungen enthaltend thymol und/oder carvacrol in der behandlung von histomoniasis
BR0210401A (pt) Composto, composição farmacêutica, uso de um composto e método para o tratamento de um distúrbio ou de uma doença de um corpo de animal vivo, incluindo um humano
CU23538B7 (es) Composiciones farmacéuticas para el tratamiento de enfermedades relacionadas a neurotrofinas
Rickert et al. Growth modulation by stimulating the growth plate: a pilot study
ATE451350T1 (de) Arylalkylsulfonamide als therapeutische mittel zur behandlung von knochenleiden